Latest Tissue plasminogen activator Stories
Placement Agent Spencer Trask Ventures Rallies investors to "Take Stock in Stroke" NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Vesselon, Inc.
HOUSTON, June 4, 2014 /PRNewswire-USNewswire/ -- The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center
REHOVOT, Israel, June 2, 2014 /PRNewswire/ -- D-Pharm Ltd.
UVA's stroke program has received the highest quality award from the American Heart Association. Charlottesville,VA (PRWEB) April 24, 2014 The American
Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability.
Using an ambulance that included a computed tomography (CT) scanner, point-of-care laboratory, telemedicine connection and a specialized prehospital stroke team resulted in decreased time to treatment for ischemic stroke.
In a study that included more than 71,000 stroke patients, implementation of a quality initiative was associated with improvement in the time to treatment and a lower risk of in-hospital death, intracranial hemorrhage (bleeding in the brain), and an increase in the portion of patients discharged to their home.
REHOVOT, Israel, March 4, 2014 /PRNewswire/ -- D-Pharm Ltd (TASE: DPRM) announced today, March 4th, 2014, the successful interim analysis of the first group of stroke patients
- A transitional zone between two communities containing the characteristic species of each.